The recent Full Federal Court decision in Zoetis Services LLC v Boehringer Ingelheim Animal Health USA Inc [2024] FCAFC 145 has highlighted fundamental flaws in the Australian patent law’s ‘best method’ requirement. While the court’s application of existing principles appears sound, the resulting analysis reveals that the requirement is not only arbitrary in its operation
Latest Post
More Posts
Hindsight by Stealth? Pre-RtB ‘Ascertainment’ After Sandoz v Bayer
Full Court Delivers Hot N Cold Comfort in Katy Perry Trade Mark Battle
Here We Go Again? Aristocrat Eyes High Court After Grant of Leave to Appeal
Have Australia’s ‘Raising the Bar’ Law Reforms Suppressed Patent Oppositions?
Large vs Small, Group Ownership vs Independent – What Factors Influenced Firms’ Patent Filing Share in 2023?
LG Again Tops Australian Patent Filings in 2023, as Most of the ‘Usual Suspects’ Return
Patent Filings in Australia Fell Again in 2023, but Applications from China are Bucking the Trend
The Major Australian Client at the Centre of David and Goliath Legal Battle Between Patent Attorney Firms
Disciplinary Decision Against Registered Attorney a Reminder of the Importance of Clear Communication and Record Keeping
Subscribe: Subscribe via RSS
Blogs
Firm/Org